National Institute of Neurological Disorders and Stroke (NINDS) mission is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.

NINDS supports and performs basic, translational, and clinical neuroscience research; funds and conducts research training and career development programs to increase basic, translational and clinical neuroscience expertise; and promotes the timely dissemination of scientific discoveries and their implications for neurological health to the public, health professionals, researchers, and policy-makers.

Walter Koroshetz, MD – NINDS

Director of the National Institute of Neurological Disorders and Stroke (NINDS)
Co-chair, BRAIN Initiative Multi-Council Working Group (MCWG)

Walter J. Koroshetz, M.D. was selected Director of NINDS on June 11, 2015. Dr. Koroshetz joined NINDS in 2007 as Deputy Director, and he served as Acting Director from October 2014 through June 2015. Before joining NINDS, Dr. Koroshetz served as Vice Chair of the neurology service and Director of stroke and neurointensive care services at Massachusetts General Hospital (MGH).

NINDS Director’s Messages

Messages from NINDS Director Walter Koroshetz, MD:

New Award Creates Stable Funding for Outstanding Neuroscience Investigators on July 16, 2105

The Privilege of Leading NINDS on July 11, 2105

Noninvasive Brain Stimulation: Applications and Implications on June 2, 2105

Robert Finkelstein, Ph.D – NINDS

Director, NINDS/NIH Division of Extramural Research
Co-Chair of the Interagency Working Group on Neuroscience

Dr. Robert Finkelstein has been the Director of the NINDS Division of Extramural Research since November 2004. In this capacity, he is responsible for planning and policy, coordinating scientific programs funded by the Institute, and overseeing the scientific review, grants management, and administrative services of the extramural program.

Michele Ferrante

Postdoctoral Scientist, Boston University
PhD in Neuroscience from George Mason University

Michele's research focus is on Whole-cell Electrophysiology, Biotechnology, Optogenetics, Neuropharmacology, and Computational Models. Michele employs Electrophysiology in brain slices - patch clamp and neuropharmacology.
implements biophysically realistic models of neurons.

Alan Willard, PhD – NINDS

Acting Deputy Director, NINDS, Office Of The Director
Designated Federal Official for the Multi-Council Working Group

Dr. Willard served as the Deputy Director of the NINDS Extramural program, Chief of the Scientific Review Branch and the Referral Officer for NINDS. He was a tenured faculty member at the University of North Carolina at Chapel Hill in the Department of Cell & Molecular Physiology and the Curriculum in Neurobiology, where his research interests were in the areas of developmental neurobiology and synaptic physiology.

Kip Ludwig

Program Director, Neural Engineering at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)
Multi-Council Working Group 

Dr. Ludwig is the Scientific Lead for the Translational Devices Program at NINDS, is a Co-Lead of the Project Team responsible for developing and executing three of the six NIH Funding Opportunities Announcements for the B.R.A.I.N. Initiative, and led a trans-NIH planning team in developing the ~$250M Stimulating Peripheral Activity to Relieve Conditions (SPARC) Program to stimulate advances in neuromodulation therapies for organ systems.

Edmund Talley, PhD – NINDS

Program Director, Extramural Research Program for National Institute for Neurological Disorders and Stroke (NINDS)
Multi-Council Working Group (Staff)

Dr. Talley was a Research Assistant Professor at UVA and initiated investigations into the CNS functions of two-pore-domain potassium channels, with an emphasis on their modulation by neurotransmitters and clinically important drugs. His work on these channels included extensive mapping of their CNS expression patterns, identification of molecular bases for their modulation using mutational and biochemical analyses, and investigations into their functions in vivo by generating knockout mouse lines.

Amy Adams, PhD – NINDS

Director, Office of Scientific Liaison, NINDS

Dr Adams leads OSL efforts to provide a seamless flow of information on research advances and initiatives to the various stakeholders including scientific and academic communities, as well as policy-makers, patients, and the public.

Khara Ramos, PhD – NINDS

Senior Science Policy Analyst, NINDS

Dr. Ramos supports the coordination and oversight of three main NINDS efforts: the NIH BRAIN Initiative; the work of NINDS's Office of Scientific Liaison communicating information on the basic and translational research funded by NINDS to diverse scientific audiences; and the work of the Office of Pain Policy. She also serves as Executive Secretary and NIH liaison for the Neuroethics Workgroup of the BRAIN Multi-Council Working Group.

National Advisory Neurological Disorders and Stroke (NANDS) Council Meetings

September 10, 2015 Meeting

Natcher Conference Center, Building 45, Conference Room E1/E2
Bethesda, Maryland 20892
Closed Circuit Viewing Overflow on September 10 (Conference Rooms F1/F2 and D)
NIH Videocast Website:

Skip to toolbar